Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
ERYTech Pharma SA ADR
ERYP
$
6.74
3.5%
Sat May 8th, 2021
19:02
Earnings
Analysis
ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q1 2021 Results - Earnings Call Transcript
Seeking Alpha
Thu May 6th, 2021
19:13
Earnings
Analysis
ERYTECH Pharma S.A. 2021 Q1 - Results - Earnings Call Presentation
Seeking Alpha
Tue March 9th, 2021
18:50
Earnings
Analysis
ERYTECH Pharma S.A. 2020 Q4 - Results - Earnings Call Presentation
Seeking Alpha
18:41
Earnings
Analysis
ERYTECH Pharma's (ERYP) CEO Gil Beyen on Q4 2020 Results - Earnings Call Transcript
Seeking Alpha
Wed January 13th, 2021
13:36
Analysis
ERYTECH Pharma (ERYP) Catches Eye: Stock Jumps 7.4%
Zacks
Sun November 8th, 2020
19:01
Earnings
Analysis
ERYTECH Pharma's (ERYP) CEO Gil Beyen on Q3 2020 Results - Earnings Call Transcript
Seeking Alpha
Fri October 23rd, 2020
08:25
Analysis
ERYTECH: Trials In Pancreatic Cancer
Seeking Alpha
Tue September 22nd, 2020
17:52
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Earnings
Analysis
ERYTECH Pharma S.A. 2020 Q2 - Results - Earnings Call Presentation
Seeking Alpha
17:45
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Earnings
Analysis
ERYTECH Pharma S.A. (ERYP) CEO Gil Beyen on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
Wed September 2nd, 2020
23:03
Analysis
Erytech Pharma: Exploring New Ways To Battle Cancer
Seeking Alpha
Tue June 2nd, 2020
16:00
Rating
Analysis
Erytech Pharma SA Sponsored ADR (ERYP) Upgraded to Buy: Here's What You Should Know
Zacks
Tue May 26th, 2020
20:00
Press Releases
Erytech's Combined Shareholders' Meeting
Benzinga
